Recent research suggests that half-body irradiation (HBI) may significantly improve survival in dogs with lymphoma.
Studies show that approximately 40–50% of patients are alive at five years. That’s nearly double the survival rate typically achieved with chemotherapy alone.
While the data are still early and not yet as extensive as chemotherapy research, chemotherapy remains the first-line treatment. However, radiotherapy is emerging as a powerful tool to extend survival.
Importantly, HBI is not meant to replace chemotherapy — it can be added on top of it.
Think of it as a boost. If your goal is to give your dog the best possible chance at a long, healthy life, radiotherapy is something worth considering alongside chemotherapy.
